Mindfulness-Based Art Therapy for Cancer Patients

针对癌症患者的正念艺术治疗

• 批准号: 6361110
• 负责人: Daniel A Monti
• 金额: $ 19.63万
• 依托单位: THOMAS JEFFERSON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-09-24 至 2003-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6361110
• 关键词: age difference; alternative medicine; arts; behavioral /social science research tag; combination cancer therapy; coping; gender difference; group therapy; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; outcomes research; patient oriented research; psychological aspect of cancer; psychological stressor; quality of life; racial /ethnic difference; stress management

DESCRIPTION (provided by applicant): Psychosocial interventions, especially supportive-expressive group therapies, have been associated with significant improvements in health status, quality of life and coping behaviors, in patients with cancer. The purpose of the proposed pilot research study is to investigate a newly developed group therapy for cancer patients, MBAT. This proposed, randomized, controlled study follows a successful preliminary investigation of MBAT conducted at Thomas Jefferson University Hospital. MBAT integrates known benefits of art therapy, group therapy, and mindfulness-based stress reduction. Each of these fundamentally different modalities has documented usefulness in the treatment of cancer patients. The multi-modal approach is designed to enhance both the supportive and expressive aspects of the group experience. The study will be done with 96 patients who have a variety of cancer types. Participants will be matched for age and assigned randomly to either the MBAT experimental group or a non-intervention control group. Both groups will continue to receive their usual oncologic/medical care. The MBAT program consists of eight weekly meetings of two and one half-hours in length. At the end of the eight weeks, participants in the control group will be crossed over to the experimental intervention arm for an additional eight weeks. Participants will be assessed pre- and post-intervention on measures of health-related quality of life, psychological distress, and coping, using standardized outcome instruments (SF-36, SCL-90-R and COPE). Our long-term goal is to collect sufficient data to determine the overall efficacy of this promising intervention and to identify which patients are particularly likely to benefit from MBAT.

描述（由申请人提供）：心理社会干预，尤其是 支持表达团体疗法与显着相关 健康状况、生活质量和应对行为的改善 癌症患者。拟议试点研究的目的是 研究一种新开发的针对癌症患者的团体疗法，MBAT。这 拟议的随机对照研究是在成功的初步研究之后进行的 在托马斯·杰斐逊大学医院进行的 MBAT 调查。 MBAT 整合了艺术疗法、团体疗法和正念疗法的已知益处 减轻压力。这些根本不同的模式中的每一种都有 已记录在治疗癌症患者中的有用性。多式联运 方法旨在增强支持性和表达性方面 团体经验。该研究将在 96 名患有以下疾病的患者中进行： 多种癌症类型。参与者将根据年龄进行匹配并分配 随机分配给 MBAT 实验组或非干预对照组 团体。两组将继续接受通常的肿瘤/医疗护理。 MBAT 计划包括每周八次会议，每次两个半小时 长度。八周结束时，对照组的参与者将 被交叉到实验干预组以获得额外的八个 几周。参与者将在干预前和干预后接受以下措施的评估： 与健康相关的生活质量、心理困扰和应对方式，使用 标准化结果工具（SF-36、SCL-90-R 和 COPE）。我们的长期目标 是收集足够的数据来确定该方案的总体功效 有前途的干预措施并确定哪些患者特别有可能 从 MBAT 中受益。